Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Epilepsia. 2013 Jan 7;54(2):314–322. doi: 10.1111/epi.12068

Table 4.

Comparisons Between Concordant and Discordant Groups

Concordant Group Discordant Group
n = 197 n = 32
Mean (SD) or % Mean (SD) or % p value
Age at surgery, y 37.4 (11.1) 39.6 (9.4) .29
Sex, % female 50% 59% .34
Education, y 13.1 (2.5) 13.6 (2.3) .29
Handedness, % right-handed 82.7% 68.8% .06
Age at epilepsy onset, y 17.7 (12.2) 16.5 (11.3) .63
Epilepsy duration, y 20.4 (14.0) 23.6 (13.6) .24
No. of AEDs 2.1 (0.9) 1.8 (0.9) .20
CAIs (topiramate or zonisamide) 14% 9% .50
Seizure focus RT/LT/ET 81/82/34 10/15/7 .55
MTS or HA 46% 44% .80
Full-scale IQ 93.0 (12.8) 94.2 (13.8) .65
Amobarbital dose, right 82.6 88.2 .14
Amobarbital dose, 86.1 89.2 .33
Wada total possible, left 21.0 (4.6) 19.3 (4.1) .05
Wada total possible, right 21.4 (6.2) 20.6 (7.5) .50
Crossflow left to right 40% 50% .29
Crossflow right to left 36% 17% .05
Obtundation 8% 16% .18
Proximal ACA atresia 5% 0% .22
PCA filling 42% 34% .41
% Correct, Semantic task 81.2 (10.3) 79.4 (12.1) .39
% Correct, Tones task 90.3 (12.0) 92.4 (10.4) .35
Head motion (RMS mean) 44.9 (70.0) 50.8 (100.6) .69
Mean residual error 122.1 (213.3) 109.2 (195.9) .75
Signal-to-fluctuation noise ratio 78.0 (26.8) 76.2 (22.8) .73
Artifact-contaminated volumes 5.0 (11.6) 8.5 (15.0) .15
Wada LI 71.2 (45.5) 24.3 (64.9) <.0001
FMRI LI 57.2 (40.0) 14.9 (50.1) <.0001

ACA, anterior cerebral artery; AED, anti-epileptic drug; CAIs, carbonic-anhydrase inhibitors; RT, right temporal; LT, left temporal; ET, extratemporal; MTS, mesial temporal sclerosis; HA, hippocampal atrophy; y, years; PCA, posterior cerebral artery; RMS, root mean square; SD, standard deviation

HHS Vulnerability Disclosure